Literature DB >> 15675603

Transient receptor potential ion channels as targets for the discovery of pain therapeutics.

James E Krause1, Bertrand L Chenard, Daniel N Cortright.   

Abstract

A subset of transient receptor potential (TRP) channels exhibits activity that is highly sensitive to temperature changes and is expressed in sensory tissues, such as nociceptors and skin. Some of these thermosensitive TRP channels, such as TRPV1, TRPV4 and TRPA1, are activated or sensitized by molecules generated by inflammation and/or cell damage. TRPV1, also known as the capsaicin receptor, is particularly important in mediating hyperalgesic responses in inflammatory pain states, as demonstrated by research in knockout animals and with small-molecule antagonists. It is anticipated that TRPV1 antagonists, and perhaps antagonists at other thermosensitive TRP channels, will provide new therapeutic options with which to treat clinical pain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15675603

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  20 in total

Review 1.  [The capsaicin receptor. "TRPing" transduction for painful stimuli].

Authors:  W Greffrath
Journal:  Schmerz       Date:  2006-06       Impact factor: 1.107

2.  Septin-2 mediates airway epithelial barrier function in physiologic and pathologic conditions.

Authors:  Venkataramana K Sidhaye; Eric Chau; Patrick N Breysse; Landon S King
Journal:  Am J Respir Cell Mol Biol       Date:  2010-09-24       Impact factor: 6.914

3.  Differential modulation of agonist and antagonist structure activity relations for rat TRPV1 by cyclosporin A and other protein phosphatase inhibitors.

Authors:  Larry V Pearce; Attila Toth; HyungChul Ryu; Dong Wook Kang; Hyun-Kyung Choi; Mi-Kyoung Jin; Jeewoo Lee; Peter M Blumberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-02-08       Impact factor: 3.000

4.  Structure-activity relationships of 1,4-dihydropyridines that act as enhancers of the vanilloid receptor 1 (TRPV1).

Authors:  Eun Joo Roh; Jason M Keller; Zoltan Olah; Michael J Iadarola; Kenneth A Jacobson
Journal:  Bioorg Med Chem       Date:  2008-08-26       Impact factor: 3.641

5.  Analgesic compound from sea anemone Heteractis crispa is the first polypeptide inhibitor of vanilloid receptor 1 (TRPV1).

Authors:  Yaroslav A Andreev; Sergey A Kozlov; Sergey G Koshelev; Ekaterina A Ivanova; Margarita M Monastyrnaya; Emma P Kozlovskaya; Eugene V Grishin
Journal:  J Biol Chem       Date:  2008-06-25       Impact factor: 5.157

Review 6.  Small molecule vanilloid TRPV1 receptor antagonists approaching drug status: can they live up to the expectations?

Authors:  Arpad Szallasi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-06-14       Impact factor: 3.000

Review 7.  Pleiotropic function of TRPV4 ion channels in the central nervous system.

Authors:  Patrick Kanju; Wolfgang Liedtke
Journal:  Exp Physiol       Date:  2016-11-08       Impact factor: 2.969

8.  Characterization of two different mucolipin-like genes from Leishmania major.

Authors:  Mehdi Chenik; Feriel Douagi; Yosser Ben Achour; Noureddine Ben Khalef; Meriem Ouakad; Hechmi Louzir; Koussay Dellagi
Journal:  Parasitol Res       Date:  2005-10-20       Impact factor: 2.289

Review 9.  Use of sensory methods for detecting target engagement in clinical trials of new analgesics.

Authors:  Boris A Chizh; Christine N Sang
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

10.  Local inflammation in rat dorsal root ganglion alters excitability and ion currents in small-diameter sensory neurons.

Authors:  Jun-Gang Wang; Judith A Strong; Wenrui Xie; Jun-Ming Zhang
Journal:  Anesthesiology       Date:  2007-08       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.